Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

Clinical trial NCT05060991 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05060991
Sponsor: University of California, Davis
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

COVID-19 Immunosuppression Vaccine Response Impaired

Start date: 2021-09-24
Primary completion: 2026-12-24
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.